- Home
- SOND vs OSRH Comparison
SOND vs OSRH Comparison
Compare SOND & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- OSRH
- Stock Information
- Founded
- SOND 2014
- OSRH N/A
- Country
- SOND United States
- OSRH United States
- Employees
- SOND N/A
- OSRH N/A
- Industry
- SOND Hotels/Resorts
- OSRH
- Sector
- SOND Consumer Discretionary
- OSRH
- Exchange
- SOND Nasdaq
- OSRH Nasdaq
- Market Cap
- SOND 23.2M
- OSRH 19.0M
- IPO Year
- SOND N/A
- OSRH N/A
- Fundamental
- Price
- SOND $2.12
- OSRH $0.64
- Analyst Decision
- SOND
- OSRH
- Analyst Count
- SOND 0
- OSRH 0
- Target Price
- SOND N/A
- OSRH N/A
- AVG Volume (30 Days)
- SOND 56.2K
- OSRH 1.4M
- Earning Date
- SOND 07-23-2025
- OSRH 08-24-2025
- Dividend Yield
- SOND N/A
- OSRH N/A
- EPS Growth
- SOND N/A
- OSRH N/A
- EPS
- SOND N/A
- OSRH N/A
- Revenue
- SOND $621,272,000.00
- OSRH N/A
- Revenue This Year
- SOND $46.47
- OSRH N/A
- Revenue Next Year
- SOND N/A
- OSRH N/A
- P/E Ratio
- SOND N/A
- OSRH N/A
- Revenue Growth
- SOND 3.19
- OSRH N/A
- 52 Week Low
- SOND $0.88
- OSRH $0.63
- 52 Week High
- SOND $10.50
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- SOND 40.81
- OSRH N/A
- Support Level
- SOND $2.11
- OSRH N/A
- Resistance Level
- SOND $2.29
- OSRH N/A
- Average True Range (ATR)
- SOND 0.17
- OSRH 0.00
- MACD
- SOND -0.10
- OSRH 0.00
- Stochastic Oscillator
- SOND 7.23
- OSRH 0.00
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.